首页> 外文期刊>Bioinformatics >Characterization of p38 MAPK isoforms for drug resistance study using systems biology approach
【24h】

Characterization of p38 MAPK isoforms for drug resistance study using systems biology approach

机译:使用系统生物学方法表征p38 MAPK亚型用于耐药性研究

获取原文
获取原文并翻译 | 示例
       

摘要

Motivation: p38 mitogen-activated protein kinase activation plays an important role in resistance to chemotherapeutic cytotoxic drugs in treating multiple myeloma (MM). However, how the p38 mitogenactivated protein kinase signaling pathway is involved in drug resistance, in particular the roles that the various p38 isoforms play, remains largely unknown.Method: To explore the underlying mechanisms, we developed a novel systems biology approach by integrating liquid chromatography-mass spectrometry and reverse phase protein array data from human MM cell lines with computational pathway models in which the unknown parameters were inferred using a proposed novel algorithm called modularized factor graph.Results: New mechanisms predicted by our models suggest that combined activation of various p38 isoforms may result in drug resistance in MM via regulating the related pathways including extracellular signal-regulated kinase (ERK) pathway and (NFDB)-B-0 pathway. ERK pathway regulating cell growth is synergistically regulated by p38 delta isoform, whereas nuclear factor kappa B ((NFDB)-B-0) pathway regulating cell apoptosis is synergistically regulated by p38 alpha isoform. This finding that p38 delta isoform promotes the phosphorylation of ERK1/2 in MM cells treated with bortezomib was validated by western blotting. Based on the predicted mechanisms, we further screened drug combinations in silico and found that a promising drug combination targeting ERK1/2 and NF kappa B might reduce the effects of drug resistance in MM cells. This study provides a framework of a systems biology approach to studying drug resistance and drug combination selection.Availability and implementation: RPPA experimental Data and Matlab source codes of modularized factor graph for parameter estimation are freely available online at ext-link-type="uri" xlink:href="http://ctsb.is.wfubmc.edu/publications/modularized-factor-gr aph.php" xlink:type="simple"http://ctsb.is.wfubmc.edu/publications/modularized-fa ctor-graph.phpC1 Zhang, Le; Southwest Univ, Coll Comp and Informat Sci, Chongqing 400715, Peoples R ChinaSC Pharmacology & Pharmacy; Cardiovascular System & Cardiology; Oncology; Immunology; Biochemistry & Molecular Biology; Mathematical & Computational Biology
机译:动机:p38丝裂原激活的蛋白激酶激活在治疗多发性骨髓瘤(MM)中对化学治疗细胞毒性药物的耐药性中起重要作用。然而,p38丝裂原活化的蛋白激酶信号转导途径如何参与耐药性,尤其是各种p38异构体所起的作用,仍然是未知的。方法:为了探索潜在的机制,我们通过整合液相色谱开发了一种新颖的系统生物学方法人MM细胞系的质谱质谱法和反相蛋白阵列数据,以及计算路径模型,其中使用提出的新型算法(称为模块化因子图)推断未知参数。结果:我们的模型预测的新机制表明,多种p38的联合激活亚型可能通过调节相关途径(包括细胞外信号调节激酶(ERK)途径和(NFDB)-B-0途径)导致MM耐药。 ERK途径调节细胞生长受p38δ亚型协同调节,而核因子κB((NFDB)-B-0)途径调节细胞凋亡受p38α亚型协同调节。 Western blotting证实了p38δ亚型促进了硼替佐米处理的MM细胞中ERK1 / 2的磷酸化。基于预测的机制,我们进一步通过计算机筛选了药物组合,发现针对ERK1 / 2和NFκB的有前途的药物组合可能会降低MM细胞耐药性的作用。这项研究为研究耐药性和药物组合选择提供了系统生物学方法的框架。可用性和实施​​:RPPA实验数据和用于参数估计的模块化因子图的Matlab源代码可从ext-link-type =“ uri免费在线获得“ xlink:href =” http://ctsb.is.wfubmc.edu/publications/modularized-factor-gr aph.php“ xlink:type =” simple“ http://ctsb.is.wfubmc.edu/publications/ Moduleized-fa ctor-graph.phpC1 Zhang,Le;西南大学分子生物学与信息科学学院,重庆400715,中国人民大学药理学与药学;心血管系统与心脏病学;肿瘤学免疫学生物化学与分子生物学;数学与计算生物学

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号